Related references
Note: Only part of the references are listed.Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague-Dawley Rats
Princy Khurana et al.
BIOMOLECULES (2019)
Inherited diseases caused by mutations in cathepsin protease genes
Stephanie Ketterer et al.
FEBS JOURNAL (2017)
Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
Max C. Petersen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Differential Location and Distribution of Hepatic Immune Cells
Maria Alice Freitas-Lopes et al.
CELLS (2017)
Cathepsin D regulates lipid metabolism in murine steatohepatitis
Tom Houben et al.
SCIENTIFIC REPORTS (2017)
Increased Cathepsin D Correlates with Clinical Parameters in Newly Diagnosed Type 2 Diabetes
Lei Liu et al.
DISEASE MARKERS (2017)
Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts
Christoph Nowak et al.
DIABETES (2016)
The insulin resistance phenotype (muscle or liver) interacts with the type of diet to determine changes in disposition index after 2 years of intervention: the CORDIOPREV-DIAB randomised clinical trial
Ruth Blanco-Rojo et al.
DIABETOLOGIA (2016)
Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial
Jasper Most et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2016)
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial
Dorien Reijnders et al.
CELL METABOLISM (2016)
Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention
Sofie M. A. Walenbergh et al.
SCIENTIFIC REPORTS (2016)
Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Infl ammation
Sofie M. A. Walenbergh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
General aspects of muscle glucose uptake
Rafael O. Alvim et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2015)
Biomarkers of insulin sensitivity and insulin resistance: Past, present and future
Se Eun Park et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2015)
Lipid-mediated muscle insulin resistance: different fat, different pathways?
Olesja Ritter et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance
Karolina Konstantynowicz-Nowicka et al.
PLOS ONE (2015)
Lysosomal Storage Diseases-Regulating Neurodegeneration
Rob U. Onyenwoke et al.
JOURNAL OF EXPERIMENTAL NEUROSCIENCE (2015)
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Rachel J. Perry et al.
NATURE (2014)
Adiponectin, driver or passenger on the road to insulin sensitivity?
Risheng Ye et al.
MOLECULAR METABOLISM (2013)
Chemerin: a potential endocrine link between obesity and type 2 diabetes
Alexandra A. Roman et al.
ENDOCRINE (2012)
Obesity and Type 2 Diabetes: What Can Be Unified and What Needs to Be Individualized?
Robert H. Eckel et al.
DIABETES CARE (2011)
Proteomic Evaluation and Validation of Cathepsin D Regulated Proteins in Macrophages Exposed to Streptococcus pneumoniae
Martin A. Bewley et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
Cathepsin D-Many functions of one aspartic protease
Petr Benes et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
How to measure hepatic insulin resistance?
S. -P. Choukem et al.
DIABETES & METABOLISM (2008)
Insulin's direct effects on the liver dominate the control of hepatic glucose production
DS Edgerton et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Plasma cathepsin D isoforms and their active metabolites increase after myocardial infarction and contribute to plasma renin activity
RH Naseem et al.
BASIC RESEARCH IN CARDIOLOGY (2005)
Cathepsin D is up-regulated in inflammatory bowel disease macrophages
M Hausmann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
M Tiikkainen et al.
DIABETES (2004)
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects
V Rotter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α.: Effect of weight loss in obese men
JM Bruun et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Mechanism by which metformin reduces glucose production in type 2 diabetes
RS Hundal et al.
DIABETES (2000)
Share Paper
